Search clinical trials for: AUT00206

Total 8 results

Autifony Therapeutics Limited

Completed

Safety, Blood Levels and Effects of AUT00206

Schizophrenia

United Kingdom
Autifony Therapeutics Limited
King's College London

Completed

Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.

Schizophrenia

United Kingdom
Autifony Therapeutics Limited

Completed

Safety, Blood Levels and Effects of AUT00201

Healthy Volunteer

United Kingdom
Autifony Therapeutics Limited

Recruiting

Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK (AUT022201)

Myoclonus Epilepsies, Progressive

United States
Autifony Therapeutics Limited

Completed

Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)

Hearing Loss | Hearing Impairment

United Kingdom
Autifony Therapeutics Limited
University of Nottingham

Completed

Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo (QUIET-1)

Tinnitus, Subjective

United Kingdom
Autifony Therapeutics Limited

Completed

Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss (CLARITY-1)

Age-Related Hearing Loss

United States
Autifony Therapeutics Limited
University of Manchester

Completed

A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males

Schizophrenia

United Kingdom

3

Subscribe